78 related articles for article (PubMed ID: 17128095)
1. [Where is the role of the genetic investigations in amyotrophic lateral sclerosis?].
Vandenberghe N
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S96-4S101. PubMed ID: 17128095
[TBL] [Abstract][Full Text] [Related]
2. [What is the role of the genetic survey in amyotrophic lateral sclerosis?].
Camu W
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S91-4S95. PubMed ID: 17128094
[TBL] [Abstract][Full Text] [Related]
3. Variants in candidate ALS modifier genes linked to Cu/Zn superoxide dismutase do not explain divergent survival phenotypes.
Broom WJ; Russ C; Sapp PC; McKenna-Yasek D; Hosler BA; Andersen PM; Brown RH
Neurosci Lett; 2006 Jan; 392(1-2):52-7. PubMed ID: 16174551
[TBL] [Abstract][Full Text] [Related]
4. [Methods of the announcement of amyotrophic lateral sclerosis diagnosis in familial forms].
Corcia P
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S122-4S126. PubMed ID: 17128099
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of familial forms of amyotrophic lateral sclerosis. Review of the literature].
Moulard B; Camu W; Malafosse A; Billiard M; Baldy-Moulinier M
Rev Neurol (Paris); 1997 Jun; 153(5):314-24. PubMed ID: 9296165
[TBL] [Abstract][Full Text] [Related]
6. D90A-SOD1 mediated amyotrophic lateral sclerosis: a single founder for all cases with evidence for a Cis-acting disease modifier in the recessive haplotype.
Parton MJ; Broom W; Andersen PM; Al-Chalabi A; Nigel Leigh P; Powell JF; Shaw CE;
Hum Mutat; 2002 Dec; 20(6):473. PubMed ID: 12442272
[TBL] [Abstract][Full Text] [Related]
7. Genetics of familial amyotrophic lateral sclerosis.
Valdmanis PN; Rouleau GA
Neurology; 2008 Jan; 70(2):144-52. PubMed ID: 18180444
[TBL] [Abstract][Full Text] [Related]
8. Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis.
Takahashi Y; Seki N; Ishiura H; Mitsui J; Matsukawa T; Kishino A; Onodera O; Aoki M; Shimozawa N; Murayama S; Itoyama Y; Suzuki Y; Sobue G; Nishizawa M; Goto J; Tsuji S
Arch Neurol; 2008 Oct; 65(10):1326-32. PubMed ID: 18852346
[TBL] [Abstract][Full Text] [Related]
9. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
10. Ciliary neurotrophic factor null alleles are not a risk factor for Charcot-Marie-Tooth disease, hereditary neuropathy with pressure palsies and amyotrophic lateral sclerosis.
Van Vught PW; Van Wijk J; Bradley TE; Plasmans D; Jakobs ME; Veldink JH; de Jong JM; Van den Berg LH; Baas F
Neuromuscul Disord; 2007 Dec; 17(11-12):964-7. PubMed ID: 17651970
[TBL] [Abstract][Full Text] [Related]
11. Progranulin genetic variability contributes to amyotrophic lateral sclerosis.
Sleegers K; Brouwers N; Maurer-Stroh S; van Es MA; Van Damme P; van Vught PW; van der Zee J; Serneels S; De Pooter T; Van den Broeck M; Cruts M; Schymkowitz J; De Jonghe P; Rousseau F; van den Berg LH; Robberecht W; Van Broeckhoven C
Neurology; 2008 Jul; 71(4):253-9. PubMed ID: 18184915
[TBL] [Abstract][Full Text] [Related]
12. FUS/TLS gene mutations are the second most frequent cause of familial ALS in the Spanish population.
Syriani E; Morales M; Gamez J
Amyotroph Lateral Scler; 2011 Mar; 12(2):118-23. PubMed ID: 21128870
[TBL] [Abstract][Full Text] [Related]
13. [Superoxyde dismutase 1 gene abnormalities in familial amyotrophic lateral sclerosis: phenotype/genotype correlations. The French experience and review of the literature].
Jafari-Schluep HF; Khoris J; Mayeux-Portas V; Hand C; Rouleau G; Camu W;
Rev Neurol (Paris); 2004 Jan; 160(1):44-50. PubMed ID: 14978393
[TBL] [Abstract][Full Text] [Related]
14. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
[TBL] [Abstract][Full Text] [Related]
15. Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis.
Coppedè F; Mancuso M; Lo Gerfo A; Carlesi C; Piazza S; Rocchi A; Petrozzi L; Nesti C; Micheli D; Bacci A; Migliore L; Murri L; Siciliano G
Neurosci Lett; 2007 Jun; 420(2):163-8. PubMed ID: 17531381
[TBL] [Abstract][Full Text] [Related]
16. Patterns of inheritance in familial ALS.
Bradley M; Bradley L; de Belleroche J; Orrell RW
Neurology; 2005 May; 64(9):1628-31. PubMed ID: 15883330
[TBL] [Abstract][Full Text] [Related]
17. [Animal models of amyotrophic lateral sclerosis].
Yamanaka K
Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment in familial ALS.
Wheaton MW; Salamone AR; Mosnik DM; McDonald RO; Appel SH; Schmolck HI; Ringholz GM; Schulz PE
Neurology; 2007 Oct; 69(14):1411-7. PubMed ID: 17909153
[TBL] [Abstract][Full Text] [Related]
19. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
Turner BJ; Talbot K
Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
[TBL] [Abstract][Full Text] [Related]
20. Disease clustering: the example of ALS, PD, dementia and hereditary ataxias in Italy.
Malaspina A; Alimonti D; Poloni TE; Ceroni M
Funct Neurol; 2002; 17(4):177-82. PubMed ID: 12675260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
